Literature DB >> 19100260

TRIM39 is a MOAP-1-binding protein that stabilizes MOAP-1 through inhibition of its poly-ubiquitination process.

San San Lee1, Nai Yang Fu, Sunil K Sukumaran, Kah Fei Wan, Qian Wan, Victor C Yu.   

Abstract

Bax, a multi-domain pro-apoptotic Bcl-2 family member, is a key regulator for the release of apoptogenic factors from mitochondria. MOAP-1, which was first isolated from a screen for Bax-associating proteins, interacts with Bax upon apoptotic induction. MOAP-1 is a short-lived protein that is constitutively degraded by the ubiquitin-proteasome system. Apoptotic stimuli upregulate MOAP-1 rapidly through inhibition of its poly-ubiquitination process. However, cellular factors that regulate the stability of MOAP-1 have not yet been identified. In this study, we report the identification of TRIM39 as a MOAP-1-binding protein. TRIM39 belongs to a family of proteins characterized by a Tripartite Motif (TRIM), consisting of RING domain, B-box and coiled-coil domain. Several TRIM family members are known to demonstrate E3 ubiquitin ligase activity. Surprisingly, TRIM39 significantly extends the half-life of MOAP-1 by inhibiting its poly-ubiquitination process. In agreement with its effect on enhancing MOAP-1 stability, TRIM39 sensitizes cells to etoposide-induced apoptosis. Conversely, knockdown of TRIM39 reduces the sensitivity of cells to etoposide-stimulated apoptosis. Furthermore, TRIM39 elevates the level of MOAP-1 in mitochondria and promotes cytochrome c release from isolated mitochondria stimulated by recombinant Bax. Together, these data suggest that TRIM39 can promote apoptosis signalling through stabilization of MOAP-1.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19100260     DOI: 10.1016/j.yexcr.2008.11.021

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  31 in total

Review 1.  Customized chemotherapy in metastatic non-small cell lung cancer (NSCLC).

Authors:  Jia Wei; Teresa Moran; Zhengyun Zou; Xiaoping Qian; Lifeng Wang; Carlos Camps; Wenjing Hu; Imane Chaib; Belén Sanchez; Lixia Xu; Niki Karachaliou; María Sanchez-Ronco; Baorui Liu; Rafael Rosell
Journal:  Transl Lung Cancer Res       Date:  2013-06

2.  TRIM32 protein sensitizes cells to tumor necrosis factor (TNFα)-induced apoptosis via its RING domain-dependent E3 ligase activity against X-linked inhibitor of apoptosis (XIAP).

Authors:  Yeung Sook Ryu; Younglang Lee; Keun Woo Lee; Chae Young Hwang; Jin-Soo Maeng; Jeong-Hoon Kim; Yeon-Soo Seo; Kwan-Hee You; Byeongwoon Song; Ki-Sun Kwon
Journal:  J Biol Chem       Date:  2011-05-31       Impact factor: 5.157

3.  Role of TRIM5α RING domain E3 ubiquitin ligase activity in capsid disassembly, reverse transcription blockade, and restriction of simian immunodeficiency virus.

Authors:  Jonghwa Kim; Christopher Tipper; Joseph Sodroski
Journal:  J Virol       Date:  2011-06-15       Impact factor: 5.103

4.  Trim39 regulates neuronal apoptosis by acting as a SUMO-targeted E3 ubiquitin-ligase for the transcription factor NFATc3.

Authors:  Meenakshi Basu-Shrivastava; Barbara Mojsa; Stéphan Mora; Ian Robbins; Guillaume Bossis; Iréna Lassot; Solange Desagher
Journal:  Cell Death Differ       Date:  2022-04-21       Impact factor: 15.828

5.  Interactive cellular proteins related to classical swine fever virus non-structure protein 2 by yeast two-hybrid analysis.

Authors:  Kai Kang; Kangkang Guo; Qinhai Tang; Yanming Zhang; Jiang Wu; Weiwei Li; Zhi Lin
Journal:  Mol Biol Rep       Date:  2012-10-18       Impact factor: 2.316

6.  TRIM39 regulates cell cycle progression and DNA damage responses via stabilizing p21.

Authors:  Lei Zhang; Yang Mei; Nai-yang Fu; Li Guan; Wei Xie; Hui-hui Liu; Chun-dong Yu; Zhenyu Yin; Victor C Yu; Han You
Journal:  Proc Natl Acad Sci U S A       Date:  2012-12-04       Impact factor: 11.205

7.  TRIM39 negatively regulates the NFκB-mediated signaling pathway through stabilization of Cactin.

Authors:  Masanobu Suzuki; Masashi Watanabe; Yuji Nakamaru; Dai Takagi; Hidehisa Takahashi; Satoshi Fukuda; Shigetsugu Hatakeyama
Journal:  Cell Mol Life Sci       Date:  2015-09-12       Impact factor: 9.261

8.  MOAP-1, UBR5 and cisplatin resistance in ovarian cancer.

Authors:  Scott T Eblen; Amber Bradley
Journal:  Transl Cancer Res       Date:  2017-02       Impact factor: 1.241

9.  Distinct functional domains of PNMA5 mediate protein-protein interaction, nuclear localization, and apoptosis signaling in human cancer cells.

Authors:  Yong Hoi Lee; Siew Wai Pang; Chit Laa Poh; Kuan Onn Tan
Journal:  J Cancer Res Clin Oncol       Date:  2016-07-16       Impact factor: 4.553

10.  Tricistronic expression of MOAP-1, Bax and RASSF1A in cancer cells enhances chemo-sensitization that requires BH3L domain of MOAP-1.

Authors:  Yong Hoi Lee; Siew Wai Pang; Esther Revai Lechtich; Khalid Shah; Samson Eugin Simon; Suriyan Ponnusamy; Ramesh Narayanan; Chit Laa Poh; Kuan Onn Tan
Journal:  J Cancer Res Clin Oncol       Date:  2020-05-06       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.